Hypertrophic cardiomyopathy is characterised by idiopathic left ventricular hypertrophy.' Nevertheless, the diagnosis encompasses a wide range of abnormalities and there are many unanswered questions, including its incidence and importance as a contributor to a community's cardiac disability. Large clinical studies have been described2-4 from centres where patients have been specifically referred with an established diagnosis because of the known interest of the unit. They report a high incidence of serious ventricular arrhythmias and sudden death with a poor long term prognosis.5 Our experience, however, is different with regard to clinical presentation, arrhythmias, and mortality. The purpose of this paper was to consider the manifestations and caseload from unselected cases of hypertrophic cardiomyopathy in a district general hospital cardiac unit.
Patients and methods
The West Birmingham health district has a population of about 320 000. A standard M mode study was performed and septal and posterior wall thickness were measured (cm) at end diastole (R wave on the electrocardiogram). Left ventricular hypertrophy was considered present if either the septum or posterior wall thickness exceeded 1*3 cm (outside two standard deviations from normal) and severe if more than 1-8 cm.8 Hypertrophic cardiomyopathy was diagnosed in the presence of two or three of the following features: asymmetrical septal hypertrophy (septum to posterior wall ratio equal to or greater than 1 5: 1), systolic anterior motion of the mitral valve, or mid-systolic closure of the aortic valve.6
Results
Hypertrophic cardiomyopathy was diagnosed in 39 consecutive patients-that is 2% of the total and 8%o of the angina investigations and 07% of the total outpatients. They were aged 15 to 76 (mean 55±7) and 22 were women; the clinical details are shown in the Table. Ten were asymptomatic, including four diagnosed during family screening, three for investigation of a murmur, and three during population screening.'2 Twelve had a family history of hypertrophic cardiomyopathy and two of sudden death. Only two patients had no abnormal cardiac signs, but two had only a systolic murmur and one added sounds alone.
The electrocardiogram was normal in three, and 32 showed a variable degree of left ventricular hypertrophy with left atrial enlargement in 23. On ambulatory monitoring 12 had supraventricular arrhythmias (established atrial fibrillation in six), two had ill sustained ventricular tachycardia, and frequent (<30/ hour) unifocal and multifocal ventricular extrasystoles were noted in five and four respectively.
On echocardiography only 13 (33%) had asymmetrical septal-hypertrophy but a further nine had a ratio greater than 1-3: 1; 21 (54%) showed systolic anterior motion of the mitral valve and 16 (41%) had midsystolic closure of the aortic valve. Echocardiographic evidence of hypertrophy was present in all but three patients, two of whom showed angiographic apical hypertrophy. 13 Cardiac catheterisation was performed in 23 While these are common features, hypertrophic cardiomyopathy is characterised by idiopathic left ventricular hypertrophy, and, using this as the principal diagnostic feature, we identified a wide range of patients. While all had idiopathic left ventricular hypertrophy, only a third fulfilled the traditional diagnostic criteria of asymmetrical septal hypertrophy and a gradient. Two of the three classical physical signs (ill sustained arterial pulse, atrial beat, and systolic murmur6) were present in 72% of these patients, however, and in 87% the electrocardiogram showed left ventricular hypertrophy. We found that the echocardiographic diagnostic criteria were not particularly helpful in patients with equivocal signs and electrocardiogram because these are based on septal hypertrophy and evidence of a gradient, but the presence of hypertrophy of some form was present in almost all. In those in whom non-invasive tests were inconclusive, to facilitate the diagnosis and exclude other causes of left ventricular hypertrophy, cardiac catheterisation and left ventriculography were performed. Cross sectional echocardiography is probably the current method of choice for detecting regional left ventricular wall hypertrophy,8 but was not available during this study.
Using these diagnostic criteria we have shown that hypertrophic cardiomyopathy is a relatively common diagnosis and occupies a not insignificant amount of cardiac workload. Clinical studies describe hypertrophic cardiomyopathy as a disease with a poor long term prognosis'8 due to serious ventricular arrhythmias.'920 Our experience, however, is different. No deaths occurred during follow up, which contrasts with a quoted annual mortality in excess of 2%, and serious ventricular arrhythmias were probably no more common than quoted for the general population.2' While our sample size and follow up were small, these differences could be accounted for in several ways. Unlike the original clinical descriptions in relatively young patients with a mean age of 25 7 years,2 "typical" hypertrophic cardiomyopathy may be found in the older patient,22 as in our study, but postmortem studies show that hypertrophic cardiomyopathy may also be an incidental finding in those dying from other causes. 23 a wide range of disease may be found. 12 27 Our patients must be representative of the disease maniShapiro, Zezulka festation in a community even though probably a large proportion remain undiagnosed. Therefore differences in clinical manifestation compared with quoted series must be attributed to selection criteria. The implications of this study, in spite of a relatively small sample and follow up, are, firstly, that the mortality of these patients does not appear to be grossly different from normal and, secondly, that while sudden death may occur in patients with apparently mild disease (especially children), the diagnosis of this condition in adults does not necessarily imply a grave prognosis. The diagnosis may encompass a wide range of disease, and if physical signs and electrocardiogram are not typical the M mode echocardiographic features of asymmetrical septal hypertrophy and systolic anterior motion of the mitral value are not usually present. The most common echocardiographic feature was the presence of hypertrophy of the posterior wall or septum, or both. We suggest that if this is present in a patient with equivocal physical signs and electrocardiogram (without a secondary cause of hypertrophy) there is a high probability of a diagnosis of hypertrophic cardiomyopathy.
We thank Dr Shyam Singh for permission to report patients under his care.
